REFERENCES

• BixlerEO.KalesA.SoldatosCR.KalesJD.HealeyS.Prevalence of sleep disorders in the Los Angeles metropolitan area.Am J Psychiatry.197913612571262314756
   PubMed Web of Science ®Google Scholar
• MellingerGD.BaiterMB.UhlenhuthEH.Insomnia and its treatment. Prevalence and correlates.Arch Gen Psychiatry.1985422252322858188
   PubMed Web of Science ®Google Scholar
• OhayonM.Epidemiological study on insomnia in the general population.Sleep.199619(suppI)S7S158723370
   PubMed Web of Science ®Google Scholar
• BaiterMB.BauerML.Patterns of prescribing and use of hypnotic drugs in the United States. In: Clift AD, ed.Sleep Disturbances and Hypnotic Drug Dependence. New York, NY: Excerpta Medica;1975
   Google Scholar
• National Center for Health Statistics.Selected Symptoms of Psychological Distress. US Public Health Service Publication 1000, Series 11, Number 37. Washington DC: US Department of Health, Education and Welfare;1970
   Google Scholar
• SteriadeM.Arousal: revisiting the reticular activating system.Science.19962722252268602506
   PubMed Web of Science ®Google Scholar
• Pace-SchottEF.HobsonJA.The neurobiology of sleep: genetics, cellular physiology and subcortical networks.Nat Rev Neurosci.2002359160512154361
   PubMed Web of Science ®Google Scholar
• LeschDR.SpireJP.Clinical electroencephalography. In: Thorpy MJ, ed.Handbook of Sleep Disorders. New York, NY: Marcel Dekker;1990131
   Google Scholar
• DijkDJ.CzeislerCA.Paradoxical timing of the arcadian rhythm of sleep propensity serves to consolidate sleep and wakefulness in humans.Neurosci Lett199416663688190360
   PubMed Web of Science ®Google Scholar
• EdgarDM.DementWC.FullerCA.Effect of SCN lesions on sleep in squirrel monkeys: evidence for opponent processes in sleep-wake regulation.J Neurosci.199313106510798441003
   PubMed Web of Science ®Google Scholar
• SaperCB.SherinJE.ElmquistJK.Role of the ventrolateral preoptic area in sleep induction. In, Hayaishi O, Inoue S, eds.Sleep and Sleep Disorders: From Molecule to Behaviour. New York, NY: Academic Press;1997
   Google Scholar
• StanerL.LuthringerR.MâcherJP.Développement de molécules actives dans l'insomnie: actualités et aspects méthodologiques.Rev Neurol (Paris).2003159(11 suppl)6S486S5514646800
   PubMedGoogle Scholar
• JonesBE.Arousal systems.Front Biosci.20038S438S45112700104
   PubMed Web of Science ®Google Scholar
• HobsonJA.Pace-SchottEF.StïckgoldR.Dreaming and the brain: toward a cognitive neuroscience of conscious states. In: Pace Schott EF, Solms M, Blagrove M, Harnad S, eds.Sleep and Dreaming. Cambridge, UK: Cambridge University Press;2003150
   Google Scholar
• LuJ.ChouTC.SaperCB.Identification of wake active neurons in the ventral periaqueductal gray (PAG). Presented at: Society of Neuroscience Meeting, 2002 November 2-7, Orlando Fla. Abstract 878.1
   Google Scholar
• MontiJM.FernandezM.JantosH.Sleep during acute dopamine agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.Neuropsychopharmacology.199031531622141985
   PubMed Web of Science ®Google Scholar
• TrampusM.FerriN.AdamiM.OnginiE.The dopamine receptor agonists, A 68930 and SKF 38393, induce arousal and suppress REM sleep in the rat.Eur J Pharmacol.199323583878100197
   PubMed Web of Science ®Google Scholar
• IsaacSO.BerridgeCW.Wake promoting actions of dopamine D1 and D2 receptor stimulation.J Pharmacol Exp Ther.200330738633894
   Web of Science ®Google Scholar
• BeuckmannCT.YanagisawaM.Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation.J Mol Med.20028032934212072908
   PubMed Web of Science ®Google Scholar
• TaheriS.ZeitzerJM.MignotE.The role of hypocretins (orexins) in sleep regulation and narcolepsy.Annu Rev Neurosci.20022528331312052911
   PubMed Web of Science ®Google Scholar
• NishinoS.RipleyB.OvereemS.LammersGJ.MignotE.Hypocretion (orexin) deficiency in human narcolepsy.Lancet.2000355394010615891
   PubMed Web of Science ®Google Scholar
• PeyronC.FarcoJ.RogersW.et al.A mutation in a rare case of early onset narcolepsy and a generalised absence of hypocretin peptides in human narcoleptic brains.Nat Med.2000699199710973318
   PubMed Web of Science ®Google Scholar
• ThannickalTC.MooreRY.NïenhuisR.et al.Reduced number of hypocretins in human narcolepsy.Neuron.20002746947411055430
   PubMed Web of Science ®Google Scholar
• SaperCB.ChouTC.ScammellTE.The sleep switch: hypothalamic control of sleep and wakefulness.Trends Neurosci.20012472673111718878
   PubMed Web of Science ®Google Scholar
• ChouTC.BjorkumAA.GaussSE.et al.Afférents to the ventrolateral preoptic nucleus.J Neurosci.20022297799011826126
   PubMed Web of Science ®Google Scholar
• BasheerR.StreckerRE.ThakkarMM.Mc CarleyRW.Adenosine and sleep-wake regulation.Progr Neurobiol.200473379396
   PubMed Web of Science ®Google Scholar
• ChamberlainNL.ArrigoniE.ChouTC.et al.Effects of adenosine on GABAergic synaptic inputs to identified ventrolateral preoptic neurons.Neuroscience.200311991391812831851
   PubMed Web of Science ®Google Scholar
• MorairtryS.RainnieD.McCarleyR.GreeneR.Dishinbition of ventrolateral preoptic area sleep-active neurons by adenosine: a new mechanism for sleep promotion.Neuroscience.200412345145714698752
   PubMed Web of Science ®Google Scholar
• ThakkarMM.WinstonS.McCarleyRW.Orexin neurons of the hypothalamus express adenosine receptors.Brain Res.200294419019412106679
   PubMed Web of Science ®Google Scholar
• ChouTC.ScammellTE.GooleyJJ.GausSE.SaperCB.LuJ.Critical role of dorsomedial hypothalamic nucleus in a wide range of behavioral circadian rhythms.J Neurosci.200323106911070214627654
   PubMed Web of Science ®Google Scholar
• DeboerT.OvereemS.VisserNA.et al.Convergence of circadian and sleep regulatory mechanisms on hypocretin-1.Neuroscience.200412972773215541893
   PubMed Web of Science ®Google Scholar
• SackRL.HughesRJ.EdgarDM.LewyAJ.Sleep-promoting effects of melatonin: at what dose, in whom, under what conditions, and by what mechanisms?Sleep.1997209089159415954
   PubMed Web of Science ®Google Scholar
• MendelsonWB.Melatonin microinjection into the medial preoptic area increases sleep in the ratLife Sci.2002712067207012175899
   PubMed Web of Science ®Google Scholar
• DorfmanLJ.JarvickME.Comparative stimulant and diuretic actions of caffeine and theobromine in man.Clin Pharmacol Ther.1970118698725481573
   PubMed Web of Science ®Google Scholar
• LiebermanHR.WurtmanRJ.EmdeGG.RobertsC.CoviellaIL.The effects of low dose of caffeine on human performance and mood.Psychopharmacology.1987923083123114783
   PubMed Web of Science ®Google Scholar
• RibeiroJA.SebastiaoAM.de MendonçaA.Adenosine receptors in the nervous system: pathophysiological implications.Prog Neurobiol.20026837739212576292
   PubMed Web of Science ®Google Scholar
• FredholmBB.BattigK.HolmenJ.NehiigA.ZwartauEE.Actions of caffeine in the brain with special reference to factors that contribute to its widespread use.Pharmacol Rev.1999518313310049999
   PubMed Web of Science ®Google Scholar
• HoppenbrowersML.BusscheGV.Mioflazine, a nucleoside transport inhibitor is it effective as a sleep promoter in humans? In: Wauqier A, Dugovïc C, Radulovacki M, et al, eds.Slow Wave Sleep: Pathophysiological and Functional Aspects. New York, NY: Raven Press;1989301309
   Google Scholar
• RadekRJ.DeckerMW.JarvisMF.The adenosine kinase inhibitor ABT702 augments EEG slow waves in rats.Brain Res.20041026748315476699
   PubMed Web of Science ®Google Scholar
• TaylorD.HoBT.Comparison of inhibition of monoamine uptake by cocaine, methylphenidate and amphetamine.Res Commun Chem Pathol Pharmacol.1978216575
   Google Scholar
• NishinoS.MaoJ.SampathkumaranR.SheltonJ.MignotE.Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants.Sleep Res Online.19981496111382857
   PubMedGoogle Scholar
• WisorJP.NishinoS.SoraI.UhlGH.MignotE.EdgarDM.Dopaminergic role in stimulant-induced wakefulness.J Neurosci.2001211787179411222668
   PubMed Web of Science ®Google Scholar
• LinJS.HouY.JouvetM.Pontential brain neuronal targets for amphetamine-, methylpenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat.Proc Natl Acad Sci USA.19969314128141338943072
   PubMed Web of Science ®Google Scholar
• EngberTM.KouryEJ.DennisSA.MillerMS.ContrerasPC.BhatRV.Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil.Neurosci Lett.199824195989507929
   PubMed Web of Science ®Google Scholar
• ScammellTE.EstabrookeIV.McCarthyMT.et al.Hypothalamic arousal regions are activated during modafinil-induced wakefulness.J Neurosci.2000208620862811069971
   PubMed Web of Science ®Google Scholar
• AkaokaH.RousselB.LinJS.ChouvetG.JouvetM.Effect of modafinil and amphetamine on the rat catecholaminergic neuron activity.Neurosci Lett.199112320241676498
   PubMed Web of Science ®Google Scholar
• LinJS.RousselB.AkaokaH.FortP.DebillyG.JouvetM.Role of catecholamines in the modafinil- and amphetamine-induced wakefulness, a comparative pharmacological study in the cat.Brain Res.19925913193261359924
   PubMed Web of Science ®Google Scholar
• de Saint HilaireZ.OroscoM.RouchC.BlancG.NicolaidisS.Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats.Neuroreport.2001123533353711733706
   PubMed Web of Science ®Google Scholar
• BrownRE.StevensDR.HaasHL.The physiology of brain histamine.Prog Neurobiol.20016363767211164999
   PubMed Web of Science ®Google Scholar
• PassaniMB.LinJS.HancockA.CrochetS.BlandinaP.The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders.TIPS.20042561862515530639
   PubMed Web of Science ®Google Scholar
• LigneauX.LinJ.Vanni-MercierG.et al.Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist.J Pharmacol Exp Ther.19982876586669808693
   PubMed Web of Science ®Google Scholar
• ParmentierR.OhtsuH.Djebbara-HannasZ.ValatxJL.WatanabeT.LinJS.Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control.J Neurosci.2002227695771112196593
   PubMed Web of Science ®Google Scholar
• KomaterVA.BrowmanKE.CurzonP.HancockAA.DeckerMW.FoxGB.H3 receptor blockade by thioperamide enhances cognition in rats without inducing locomotor sensitization.Psychopharmacology.200316736337212682709
   PubMed Web of Science ®Google Scholar
• SakuraiT.AmemiyaA.IshiiM.et al.Orexins and orexin receptors: a family of hypothalamic neuropeptides and G proteincoupled receptors that regulate feeding.Cell.1998925735789491897
   PubMed Web of Science ®Google Scholar
• TrivediP.YuH.MacNeilDJ.Van der PloegLH.GuanXM.Distribution of orexin receptor mRNA in the rat brain.FEBS Lett.199843871759821961
   PubMed Web of Science ®Google Scholar
• MarcusJN.AschkenasiCJ.LeeCE.et al.Differential expression of orexin receptors 1 and 2 in the rat brain.J Comp Neurol.200143562511370008
   PubMed Web of Science ®Google Scholar
• LinL.FaracaoJ.LiR.et al.The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene.Cell.19999836537610458611
   PubMed Web of Science ®Google Scholar
• AkanmuMA.HondaK.Selective stimulation of orexin receptor type 2 promotes wakefulness in freely behaving rats.Brain Res.2005104813814515919057
   PubMed Web of Science ®Google Scholar
• MontiJM.JantosH.PonzoniA.MontiD.Sleep and waking during acute histamine H3 agonist BP 2.94 or H3 antagonist carboperamide (MR 16155) administration in rats.Neuropsychopharmacology.19961531358797189
   PubMed Web of Science ®Google Scholar
• LinJS.Brain structure and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons.Sleep Med Rev.2000447150317210278
   PubMed Web of Science ®Google Scholar
• EspanaRA.ValentinoRJ.BerridgeCW.Fos immunoreactivity in hypocretin-synthesizing and hypocretin-1 receptor-expressing neurons: effects of diurnal and nocturnal spontaneous waking, stress and hypocretin-1 administration.Neuroscience.200312120121712946712
   PubMed Web of Science ®Google Scholar
• Winsky-SommererR.YamanakaA.DïanoS.et al.Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response.J Neurosci.200424114391144815601950
   PubMed Web of Science ®Google Scholar
• Schneider-HelmertD.Twenty-four hour sleep-wake function and personality pattern in chronic insomniacs and healthy controls.Sleep.1987104524623685753
   PubMed Web of Science ®Google Scholar
• StepanskiE.ZorickF.RoehrsT.YoungD.RothT.Daytime alertness in patients with chronic insomnia compared with asymptomatic control subjects.Sleep.19881154603363270
   PubMed Web of Science ®Google Scholar
• RegensteinQH.DambrosiaJ.HallettM.MurawskiB.PaineM.Daytime alertness in patients with primary insomnia.Am J Psychiatry.1993150152915348379559
   PubMed Web of Science ®Google Scholar
• StanerL.CornetteF.MauriceD.et al.Sleep microstructure around sleep onset differentiates major depressive insomnia from primary insomnia.J Sleep Res.20031231933014633244
   PubMed Web of Science ®Google Scholar
• VgontzasAN.BixlerEO.LinHM.et al.Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications.J Clin Endocr Metab.2001863787379411502812
   PubMed Web of Science ®Google Scholar
• BonnetMH.ArandDL.Heart rate variability in insomniacs and matched normal sleepers.Psychosom Med.1998606106159773766
   PubMed Web of Science ®Google Scholar
• MileykovskiyBY.KiyashchenkoLI.SiegelJM.Behavioral correlates of activity in identified hypocretin/orexin neurons.Neuron.20054678779815924864
   PubMed Web of Science ®Google Scholar
• ProsiseGL.BonnetMH.BerryRB.DickelMJ.Effects of abstinence from smoking on sleep and daytime sleepiness.Chest.1994105113611418162739
   PubMed Web of Science ®Google Scholar
• WetterDW.FioreMC.BakerTB.YoungTB.Tobacco withdrawal and nicotine replacement influence objective measures of sleep.J Consult Clin Psychology.199563658667
   PubMed Web of Science ®Google Scholar
• JorenbyDE.SmithSS.FioreMC.et al.Varying nicotine patch dose and type of smoking cessation counselling.JAMA.1995274134713527563558
   PubMed Web of Science ®Google Scholar
• GreenlandS.SatterfieldMH.LanesSF.A meta-analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch.Drug Safety.1998182973089565740
   PubMed Web of Science ®Google Scholar
• GourlaySG.ForbesA.MarrïnerT.McNeilJJ.Predictors of adverse experiences during transdermal nicotine therapy.Drug Safety.19992054555510392670
   PubMed Web of Science ®Google Scholar
• Salin-PascualRJ.Moro-LopezML.Gonzalez-SanchezH.Bianco-CenturionC.Changes in sleep after acute and repeated administration of nicotine in the rat.Psychopharmacology.199914513313810463313
   PubMed Web of Science ®Google Scholar
• LenaC.PopaD.GrailheR.EscourrouP.ChangeuxJP.AdrienJ.p2-containing nicotinic receptors contribute to the organization of sleep and regulate putative microarousals in mice.J Neurosci.2004245711571815215293
   PubMed Web of Science ®Google Scholar
• GillinJC.LardonM.RuizC.GolshanS.SalinpascualR.Dose-dependent effects of transdermal nicotine on early morning awakening and rapid eye movement sleep time in non-smoking normal volunteers.J Clin Psychopharmacol.1994142642677962682
   PubMed Web of Science ®Google Scholar
• DavilaDG.HurtRD.OffordKP.HarrisCD.ShepardJW.Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers.Am J Resp Critic Care Med.1994150469471
   PubMed Web of Science ®Google Scholar
• StanerL.LuthringerR.DupontC.AubinHJ.LagrueG.Sleep effects of a 24-hour versus a 16-hour nicotine patch: a polysomnographic study during smoking cessation.Sleep Med. 2005. In press.
   Google Scholar
• BrowerKJ.Alcohol's effects on sleep in alcoholics.Alcohol Res Health.20012511012511584550
   PubMedGoogle Scholar
• LittleHJ.The contribution of electrophysiology to knowledge of acute and chronic effects of ethanoi.Pharmacol Ther.19998433335310665833
   PubMed Web of Science ®Google Scholar
• KrystalJH.PetrakisIL.MasonG.TrevisanL.D'SouzaDC.N-Methyl-Daspartate glutamate receptors and alcoholism: reward, dependence, treatment and vulnerability.Pharmacol Ther.200399799412804700
   PubMed Web of Science ®Google Scholar
• GrantKA.LovingerDM.Cellular and behavioural neurobiology of alcohol: receptor-mediated neuronal processes.Clin Neurosci.199531551648612060
   PubMedGoogle Scholar
• WoodwardJJ.lonotropic glutamate receptors as sites of action for ethanoi in the brain.Neurochem Int.19993510711310405994
   PubMed Web of Science ®Google Scholar
• HolterSM.DanyszW.SpanagelR.Evidence for alcohol anti-craving properties of memantine.Eur J Pharmacol.1996314R1R28957265
   PubMed Web of Science ®Google Scholar
• HolterSM.DanyszW.SpanagelR.Novel uncompetitive A/-methyl-Daspartate (NMDA)-receptor antagonist MRZ 2/579 suppresses ethanoi intake in long-term ethanol-experienced rats and generalizes to ethanoi cue in drug discrimination procedure.J Pharmacol Exp Ther.200029254555210640291
   PubMed Web of Science ®Google Scholar
• MasonBJ.Treatment of alcohol dependent outpatients with acamprosate: a clinical review.J Clin Psychiatry.200162424811584875
   PubMed Web of Science ®Google Scholar
• BobN.NedelecJF.MuzetM.et al.Central effects of acamprosate: part 2. Acamprosate modifies the brain in-vivo proton magnetic resonance spectrum in healthy young male volunteers.Psychiatry Res.1998821151279754454
   PubMed Web of Science ®Google Scholar
• SchneiderU.WohlfartK.Schulze-BonhageA.et al.Lack of psychotomimetic or impairing effect on psychomotor performance of acamprosate.Pharmacopsychiatry.199831110113
   Web of Science ®Google Scholar
• BoeijingaPH.ParotP.SouffletL.et al.Pharmacodynamic effects of acamprosate on markers of cerebral function in alcohol-dependent subjects administered as pretreatment and during alcohol abstinence.Neuropsychobiology.200450717715179024
   PubMed Web of Science ®Google Scholar
• MöhlerH.FritschyJM.RudolphU.A new benzodiazepine pharmacology.J Pharmacol Exp Ther.20023002811752090
   PubMed Web of Science ®Google Scholar
• SteriadeM.Corticothalamic resonance, states of vigilance and mentation.Neuroscience.200010124327611074149
   PubMed Web of Science ®Google Scholar
• ToblerI.KoppC.DeboerT.RudolphU.Diazepam-induced changes in sleep: role of α1 GABAA receptor subtype.Proc Natl Acad Sci USA.2001986646664911371608
   PubMed Web of Science ®Google Scholar
• KoppC.RudolphU.KeistR.ToblerI.Diazepam-induced changes on sleep and the EEG spectrum in mice: role of the α3 GABAA receptor subtype.Eur J Neurosci.2003172226223012786990
   PubMed Web of Science ®Google Scholar
• KoppC.RudolphU.LowK.ToblerI.Modulation of rhythmic brain activity by diazepam: GABAA receptor subtype and state specificity.Proc Natl Acad Sci US A.200410136743679
   PubMed Web of Science ®Google Scholar
• LancelM.Role of GABAA receptors in the regulation of sleep: initial sleep responses to peripherally administered modulators and agonists.Sleep.19992233429989364
   PubMed Web of Science ®Google Scholar
• GottesmanC.GABA mechanisms and sleep.Neuroscience.200211123123911983310
   PubMed Web of Science ®Google Scholar
• MendelsonWB.GillinJC.WyattRD.Human Sleep and its Disorders. New York, NY: Plenum;1977
   Google Scholar
• ReynoldsCF III.KupferDJ.Sleep research in affective illness: state of the art circa 1987.Sleep.1987101992153306874
   PubMed Web of Science ®Google Scholar
• BuysseDJ.KupferDJ.Diagnostic and research applications of electroencephalographic sleep studies in depression: conceptual and methodological issues.J Nerv Ment Dis.19901784054142195133
   PubMed Web of Science ®Google Scholar
• InselTR.GillinJC.MooreA.et al.The sleep of patients with obsessivecompulsive disorder.Arch Gen Psychiatry.198239137213777149896
   PubMed Web of Science ®Google Scholar
• UhdeTW.Roy-ByrneP.GillinJC.et al.The sleep of patients with panic disorder. A preliminary report.Psychiatry Res.1984122512596593756
   PubMed Web of Science ®Google Scholar
• RosaRR.BonnetMH.KramerM.The relationship of sleep and anxiety in anxious subjects.Biol Psychol.1983161191266850022
   PubMed Web of Science ®Google Scholar
• ReynoldsCF 3rd.SoloffPH.KupferDJ.et al.Depression in borderline patients: a prospective EEG sleep study.Psychiatry Res.1985141153857645
   PubMed Web of Science ®Google Scholar
• KatzJL.KuperbergA.PollackCP.et al.Is there a relationship between eating disorder and affective disorder? New evidence from sleep recordings.AmJ Psychiatry.19841417537596731616
   PubMed Web of Science ®Google Scholar
• MoellerFG.GillinJC.IrwinM.et al.A comparison of sleep EEGs in patients with primary major depression and major depression secondary to alcoholism.J Affect Disord.19932739428432959
   PubMed Web of Science ®Google Scholar
• McCarleyRW.REM sleep and depression: common neurobiological control mechanisms.Am J Psychiatry.19821395655706122380
   PubMed Web of Science ®Google Scholar
• StanerL.LuthringerR.MâcherJP.Effects of antidepressant drugs on sleep EEG in patients with major depression. Mechanisms and therapeutic implications.CNS Drugs.1999114960
   Web of Science ®Google Scholar
• NofzingerEA.BuysseDJ.GermainA.et al.Increased activation of anterior paralimbic and executive cortex from waking to rapid eye movement sleep in depression.Arch Gen Psychiatry.20046169567215237081
   PubMed Web of Science ®Google Scholar
• RiemannD.BergerM.VoderholzerU.Sleep and depression - results from psychobiological studies: an overview.Biol Psychol.2001576710311454435
   PubMed Web of Science ®Google Scholar
• GillinJC.SitaramN.WehrT.et al.Sleep and affective illness. In, Post RM, Ballenger JC, eds.Neurobiology of Mood Disorders. Baltimore, Md: Williams SWilkins;1984157188
   Google Scholar
• MooreP.GillinJC.BhattiT.et al.Rapid tryptophan depletion, sleep electroencephalogram, and mood in men with remitted depression on serotonin reuptake inhibitors.Arch Gen Psychiatry.1998555345399633672
   PubMed Web of Science ®Google Scholar
• EvansL.GolshanS.KelsoeJ.et al.Effects of rapid tryptophan depletion on sleep electroencephalogram and mood in subjects with partially remitted depression on bupropion.Neuropsychopharmacology.2002271016102612464458
   PubMed Web of Science ®Google Scholar
• LandoltHP.KelsoeJR.RapaportMH.GillinJC.Rapid tryptophan depletion reverses phenelzine-induced suppression of REM sleep.J Sleep Res.200312131812603782
   PubMed Web of Science ®Google Scholar
• HaynesPL.McQuaidJR.KelsoeJ.et al.Affective state and EEG sleep profile in response to rapid tryptophan depletion in recently recovered nonmedicated depressed individuals.J Affect Disord.20048325326215555723
   PubMed Web of Science ®Google Scholar
• BhattiT.GillinJC.SeifritzE.et al.Effects of a tryptophan-free amino acid drink challenge on normal human sleep electroencephalogram and sleep.Biol Psychiatry.19984352599442344
   PubMed Web of Science ®Google Scholar
• VoderholzerU.HornyakM.ThielB.et al.Impact of experimentally induced serotonin deficiency by tryptophan depletion on sleep EEG in healthy subjects.Neuropsychopharmacology.1998181121249430135
   PubMed Web of Science ®Google Scholar